Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Elias Zerhouni Talks Public Health Challenges, Culture Wars at WBBA Annual Meeting
|
Gregory T. Huang |
11/06/09 |
Seattle
|
|
Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss Drugs
|
Luke Timmerman |
11/02/09 |
San Diego
|
|
Arena Positions Weight Loss Drug as the One That Won’t Raise Your Blood Pressure
|
Luke Timmerman |
10/27/09 |
San Diego
|
|
Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug
|
Luke Timmerman |
09/29/09 |
San Diego
|
|
Arena Obesity Drug Passes Second Trial, Aims to Sell Safe Option for Millions of People
|
Luke Timmerman |
09/18/09 |
San Diego
|
|
Amylin Targets Obesity, Tioga Shows Virtual Business Model, Roka Bioscience Spins Off Gen-Probe, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
09/17/09 |
San Diego
|
|
Amylin, Dark Horse of the Obesity Drug Battle, Follows Fast Behind Arena, Orexigen
|
Luke Timmerman |
09/14/09 |
San Diego
|
|
Arena Prepares to Release Big Obesity Study, Minnow Medical Goes Into ‘Commercialization Mode,’ Metabasis Hires Strategic Adviser, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
09/10/09 |
San Diego
|
|
Vivus, Rival to Arena and Orexigen, Nails Big Results in Clinical Trials of Obesity Drug
|
Luke Timmerman |
09/09/09 |
San Diego
|
|
Arena Eagerly Awaits Answer to $1 Billion Question: Does It Have a Big-Time Obesity Drug?
|
Luke Timmerman |
09/08/09 |
San Diego
|
|
Ailing Metabasis Hires Advisory Firm
|
Bruce V. Bigelow |
09/03/09 |
San Diego
|
|
Orexigen Aims to Redefine Obesity, as Amgen Vet Revamps Company to Compete
|
Luke Timmerman |
09/02/09 |
San Diego
|
|
Sweet Deal With Firmenich Gives Senomyx Clear Path Forward
|
Bruce V. Bigelow |
08/04/09 |
San Diego
|
|
Orexigen Raises $70M
|
Luke Timmerman |
07/23/09 |
San Diego
|
|
Orexigen Obesity Drug Hits Weight Loss Goal in Studies, Company Looks Toward FDA
|
Luke Timmerman |
07/20/09 |
San Diego
|
|
Arena Raises $52.1M in Offering
|
Bruce V. Bigelow |
07/09/09 |
San Diego
|
|
EndoGastric Gets $7.5M
|
Gregory T. Huang |
07/08/09 |
Seattle
|
|
Arena Lines Up $100 Million in Final Push for Obesity Drug
|
Bruce V. Bigelow |
06/17/09 |
San Diego
|
|
Anadys Cuts Jobs, Obesity Drug Developers Show Intriguing Results, Trius Antibiotic Passes Key Test, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
06/11/09 |
San Diego
|
|
Arena Obesity Drug Helps Patients Shed a Few Pounds, Lower Risk of Heart Disease
|
Luke Timmerman |
06/06/09 |
San Diego
|
|
Orexigen Obesity Drug Produces “Modest” Weight Loss, Lowers Cardiovascular Risk
|
Luke Timmerman |
06/06/09 |
San Diego
|
|
GI Dynamics Adds Device to Gut Liner to Increase Weight Loss
|
Ryan McBride |
04/29/09 |
Boston
|
|
Orexigen Names New CEO
|
Juha-Pekka Tikka |
03/31/09 |
San Diego
|
|
Arena Obesity Drug Helps Patients Lose Weight, Without Heart Damage
|
Luke Timmerman |
03/30/09 |
San Diego
|
|
Arena Gets $50M Commitment
|
Luke Timmerman |
03/24/09 |
San Diego
|
|
Surface Logix, Developer of Obesity and Diabetes Drugs, Nabs $20M Financing
|
Luke Timmerman |
03/09/09 |
Boston
|
|
Arena Weight Loss Drug Approaches Critical Turning Point Next Month
|
Luke Timmerman |
02/11/09 |
San Diego
|
|
GI Dynamics Gains $15 Million to Help Patients Lose Weight
|
Ryan McBride |
02/09/09 |
Boston
|
|
The Greater Boston Diabetes Cluster
|
Ryan McBride |
02/09/09 |
Boston
|
|
Zafgen Cuts Deal With Argenta
|
Luke Timmerman |
01/29/09 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
